Home ETF List About

Portfolio Holdings Detail for ISIN IE00B43HR379
Stock Name / FundiShares S&P 500 Health Care Sector UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares V Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300QETNU1W5JY7Z94
ETF TickerIHCU(GBX) LSE
ETF TickerIUHC(USD) LSE
ETF TickerQDVG(EUR) F
ETF TickerIHCU.LS(GBX) CXE
ETF TickerIUHC.LS(USD) CXE
ETF TickerIUHCz(USD) CXE
ETF TickerQDVG.DE(EUR) CXE
ETF TickerIHCU.L(GBP) LSE
ETF TickerIUHC.L(GBP) LSE

Holdings detail for CRL

Stock NameCreightons Plc
TickerCRL(GBX) LSE
TYPECommon Stock
CountryUK
ISINGB0002341666
LEI213800WROWAJUBGSAJ57

Show aggregate CRL holdings

News associated with CRL

Charles River Laboratories International (NYSE:CRL) Downgraded to “Buy” Rating by Wall Street Zen
Wall Street Zen lowered shares of Charles River Laboratories International (NYSE:CRL – Free Report) from a strong-buy rating to a buy rating in a report issued on Sunday morning. Several other research firms also recently issued reports on CRL. Evercore ISI lifted their price target on Charles River Laboratories International from $180.00 to $190.00 and […] - 2025-09-22 03:13:04
Charles River CFO Flavia Pease To Step Down; Michael Knell Appointed Interim CFO
(RTTNews) - Charles River Laboratories International, Inc. (CRL) announced Tuesday that Flavia H. Pease, corporate executive vice president and chief financial officer, has resigned effective September 29, 2025, to pursue another opportunity. - 2025-09-16 08:28:15
Brokerages Set Charles River Laboratories International, Inc. (NYSE:CRL) PT at $175.69
Charles River Laboratories International, Inc. (NYSE:CRL – Get Free Report) has received a consensus rating of “Hold” from the fifteen research firms that are covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, nine have given a hold recommendation and five have given a buy recommendation to […] - 2025-08-29 04:49:03
Wall Street Zen Downgrades Charles River Laboratories International (NYSE:CRL) to Buy
Charles River Laboratories International (NYSE:CRL – Get Free Report) was downgraded by equities researchers at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a research note issued to investors on Sunday. CRL has been the topic of a number of other reports. Robert W. Baird upped their price objective on Charles […] - 2025-08-19 02:50:57
Maryland State Retirement & Pension System Reduces Stock Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)
Maryland State Retirement & Pension System lessened its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 18.2% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,387 shares of the medical research company’s stock after […] - 2025-08-17 05:17:00
Charles River Laboratories International, Inc. (NYSE:CRL) Shares Acquired by Charles Schwab Investment Management Inc.
Charles Schwab Investment Management Inc. boosted its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 4.4% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 577,322 shares of the medical research company’s stock after purchasing an additional 24,347 […] - 2025-08-13 05:42:56
Federated Hermes Inc. Lowers Position in Charles River Laboratories International, Inc. (NYSE:CRL)
Federated Hermes Inc. cut its holdings in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 90.6% in the first quarter, Holdings Channel reports. The fund owned 225 shares of the medical research company’s stock after selling 2,172 shares during the quarter. Federated Hermes Inc.’s holdings in Charles River Laboratories International were worth $34,000 […] - 2025-08-12 05:06:53
Analysts Expect 10% Gains Ahead For The Holdings of SPUS
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-08-11 10:38:26
Kestra Private Wealth Services LLC Sells 115 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)
Kestra Private Wealth Services LLC lowered its stake in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 5.6% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,929 shares of the medical research company’s stock after selling 115 […] - 2025-07-28 05:24:49
Charles River Laboratories International, Inc. (NYSE:CRL) Shares Sold by Mutual of America Capital Management LLC
Mutual of America Capital Management LLC trimmed its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 2.9% in the first quarter, HoldingsChannel reports. The institutional investor owned 5,938 shares of the medical research company’s stock after selling 179 shares during the period. Mutual of America Capital Management LLC’s holdings […] - 2025-07-22 07:06:50
Arizona State Retirement System Sells 336 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)
Arizona State Retirement System decreased its holdings in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 2.2% in the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 14,659 shares of the medical research company’s stock after selling 336 shares during the quarter. Arizona […] - 2025-07-18 05:10:58
Nisa Investment Advisors LLC Decreases Stock Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)
Nisa Investment Advisors LLC reduced its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 23.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,737 shares of the medical research company’s stock after selling 1,417 shares during […] - 2025-07-16 05:44:56
Brown Advisory Inc. Has $334,000 Stock Position in Charles River Laboratories International, Inc. (NYSE:CRL)
Brown Advisory Inc. lowered its holdings in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 84.9% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,219 shares of the medical research company’s stock after selling 12,506 shares during the period. Brown Advisory […] - 2025-07-16 04:56:59
Teacher Retirement System of Texas Takes $1.23 Million Position in Charles River Laboratories International, Inc. (NYSE:CRL)
Teacher Retirement System of Texas acquired a new stake in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) in the 1st quarter, Holdings Channel.com reports. The institutional investor acquired 8,180 shares of the medical research company’s stock, valued at approximately $1,231,000. Several other hedge funds also recently modified their holdings of the stock. Aaron […] - 2025-07-13 06:14:56
Charles River Laboratories International Reaches Analyst Target Price
In recent trading, shares of Charles River Laboratories International Inc. (Symbol: CRL) have crossed above the average analyst 12-month target price of $158.64, changing hands for $158.97/share. When a stock reaches the target an analyst has set, the analyst logically has two w - 2025-07-10 07:56:40
Charles River Laboratories International, Inc. (NYSE:CRL) Given Average Recommendation of “Hold” by Analysts
Charles River Laboratories International, Inc. (NYSE:CRL – Get Free Report) has received an average rating of “Hold” from the sixteen ratings firms that are covering the firm, MarketBeat reports. One analyst has rated the stock with a sell recommendation, eleven have assigned a hold recommendation and four have assigned a buy recommendation to the company. […] - 2025-07-07 04:26:46
New York State Teachers Retirement System Sells 4,446 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)
New York State Teachers Retirement System lessened its holdings in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 9.8% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 40,784 shares of the medical research company’s stock after selling 4,446 shares […] - 2025-07-06 07:56:57
Sequoia Financial Advisors LLC Has $264,000 Position in Charles River Laboratories International, Inc. (NYSE:CRL)
Sequoia Financial Advisors LLC reduced its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 10.6% in the first quarter, HoldingsChannel.com reports. The fund owned 1,755 shares of the medical research company’s stock after selling 207 shares during the quarter. Sequoia Financial Advisors LLC’s holdings in Charles River Laboratories International […] - 2025-07-04 04:45:03
Charles River Laboratories International, Inc. (NYSE:CRL) Shares Sold by Wealth Enhancement Advisory Services LLC
Wealth Enhancement Advisory Services LLC trimmed its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 4.1% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 5,723 shares of the medical research company’s stock after selling 247 shares during the period. […] - 2025-07-03 04:26:50
Bessemer Group Inc. Sells 16,538 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)
Bessemer Group Inc. trimmed its position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 70.5% during the first quarter, HoldingsChannel.com reports. The fund owned 6,935 shares of the medical research company’s stock after selling 16,538 shares during the quarter. Bessemer Group Inc.’s holdings in Charles River Laboratories International were worth $1,044,000 at […] - 2025-07-01 05:46:49
Asset Management One Co. Ltd. Sells 17,428 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)
Asset Management One Co. Ltd. lessened its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 92.1% during the first quarter, according to the company in its most recent disclosure with the SEC. The fund owned 1,490 shares of the medical research company’s stock after selling 17,428 shares during the […] - 2025-07-01 04:54:50
Congress Trade: Representative Jefferson Shreve Just Disclosed New Stock Trades
Representative Jefferson Shreve just filed new stock trades, which we received from a STOCK Act disclosure. You can see the full list of trades on Quiver Quantitative's congress trading dashboard, and track the portfolios of Representative Jefferson Shreve and other politicians. - 2025-06-23 10:13:39
Charles River Laboratories International, Inc. (NYSE:CRL) Shares Purchased by Blue Trust Inc.
Blue Trust Inc. grew its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 60.1% in the 1st quarter, HoldingsChannel.com reports. The fund owned 2,407 shares of the medical research company’s stock after acquiring an additional 904 shares during the period. Blue Trust Inc.’s holdings in Charles River Laboratories International […] - 2025-06-23 06:18:50
Yousif Capital Management LLC Has $856,000 Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)
Yousif Capital Management LLC lowered its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 3.6% in the first quarter, Holdings Channel.com reports. The firm owned 5,687 shares of the medical research company’s stock after selling 215 shares during the period. Yousif Capital Management LLC’s holdings in Charles River Laboratories […] - 2025-06-20 04:32:47
Tuesday Sector Laggards: Healthcare, Technology & Communications
The worst performing sector as of midday Tuesday is the Healthcare sector, showing a 1.4% loss. Within the sector, Charles River Laboratories International Inc. (Symbol: CRL) and Align Technology Inc (Symbol: ALGN) are two large stocks that are lagging, showing a loss of 4.4% an - 2025-06-17 15:32:11
Fifth Third Bancorp Lowers Stock Position in Charles River Laboratories International, Inc. (NYSE:CRL)
Fifth Third Bancorp lowered its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 18.8% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 8,747 shares of the medical research company’s stock after selling 2,030 shares during the […] - 2025-06-16 05:32:50
Handelsbanken Fonder AB Has $1.74 Million Stake in Charles River Laboratories International, Inc. (NYSE:CRL)
Handelsbanken Fonder AB reduced its position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 7.2% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 11,537 shares of the medical research company’s stock after selling 900 shares during the […] - 2025-06-15 06:40:51
Congress Asset Management Co. Sells 1,482 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)
Congress Asset Management Co. lessened its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 34.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,879 shares of the medical research company’s stock after selling 1,482 shares during […] - 2025-06-10 05:04:52
Rhumbline Advisers Has $13.06 Million Stake in Charles River Laboratories International, Inc. (NYSE:CRL)
Rhumbline Advisers boosted its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 4.1% in the first quarter, HoldingsChannel reports. The firm owned 86,730 shares of the medical research company’s stock after acquiring an additional 3,405 shares during the period. Rhumbline Advisers’ holdings in Charles River Laboratories International were worth […] - 2025-06-09 06:02:56
Universal Beteiligungs und Servicegesellschaft mbH Invests $3.58 Million in Charles River Laboratories International, Inc. (NYSE:CRL)
Universal Beteiligungs und Servicegesellschaft mbH bought a new position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 19,410 shares of the medical research company’s stock, valued at approximately $3,583,000. A number of other […] - 2025-06-02 05:58:52

iShares S&P 500 Health Care Sector UCITS ETF USD (Acc) CRL holdings

DateNumber of CRL Shares HeldBase Market Value of CRL SharesLocal Market Value of CRL SharesChange in CRL Shares HeldChange in CRL Base ValueCurrent Price per CRL Share HeldPrevious Price per CRL Share Held
2025-11-05 (Wednesday)24,049CRL holding decreased by -27USD 4,033,017CRL holding decreased by -248900USD 4,033,017-27USD -248,900 USD 167.7 USD 177.85
2025-11-04 (Tuesday)24,076CRL holding increased by 27USD 4,281,917CRL holding decreased by -19487USD 4,281,91727USD -19,487 USD 177.85 USD 178.86
2025-11-03 (Monday)24,049USD 4,301,404CRL holding decreased by -29099USD 4,301,4040USD -29,099 USD 178.86 USD 180.07
2025-10-31 (Friday)24,049CRL holding increased by 135USD 4,330,503CRL holding increased by 47266USD 4,330,503135USD 47,266 USD 180.07 USD 179.11
2025-10-30 (Thursday)23,914CRL holding decreased by -162USD 4,283,237CRL holding decreased by -54054USD 4,283,237-162USD -54,054 USD 179.11 USD 180.15
2025-10-29 (Wednesday)24,076CRL holding decreased by -54USD 4,337,291CRL holding decreased by -197460USD 4,337,291-54USD -197,460 USD 180.15 USD 187.93
2025-10-28 (Tuesday)24,130CRL holding increased by 52USD 4,534,751CRL holding decreased by -167201USD 4,534,75152USD -167,201 USD 187.93 USD 195.28
2025-10-27 (Monday)24,078CRL holding decreased by -54USD 4,701,952CRL holding decreased by -53017USD 4,701,952-54USD -53,017 USD 195.28 USD 197.04
2025-10-24 (Friday)24,132USD 4,754,969CRL holding increased by 146481USD 4,754,9690USD 146,481 USD 197.04 USD 190.97
2025-10-23 (Thursday)24,132USD 4,608,488CRL holding increased by 95804USD 4,608,4880USD 95,804 USD 190.97 USD 187
2025-10-22 (Wednesday)24,132CRL holding decreased by -27USD 4,512,684CRL holding decreased by -35489USD 4,512,684-27USD -35,489 USD 187 USD 188.26
2025-10-21 (Tuesday)24,159USD 4,548,173CRL holding increased by 99535USD 4,548,1730USD 99,535 USD 188.26 USD 184.14
2025-10-20 (Monday)24,159USD 4,448,638CRL holding increased by 135773USD 4,448,6380USD 135,773 USD 184.14 USD 178.52
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of CRL by Blackrock for IE00B43HR379

Show aggregate share trades of CRL

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-05SELL-27170.140160.010 161.023GBX -4,348 160.60 Loss of -12 on sale
2025-11-04BUY27180.185175.827 176.262GBX 4,759 160.51
2025-10-31BUY135181.560178.170 178.509GBX 24,099 160.33
2025-10-30SELL-162182.040177.490 177.945GBX -28,827 160.23 Loss of -2,869 on sale
2025-10-29SELL-54180.150191.410 190.284GBX -10,275 160.14 Loss of -1,628 on sale
2025-10-28BUY52187.930193.470 192.916GBX 10,032 160.00
2025-10-27SELL-54195.280198.000 197.728GBX -10,677 159.82 Loss of -2,047 on sale
2025-10-22SELL-27187.000190.690 190.321GBX -5,139 159.34 Loss of -837 on sale
2025-10-17SELL-108178.520178.770 178.745GBX -19,304 158.96 Loss of -2,137 on sale
2025-10-16BUY135174.950177.750 177.470GBX 23,958 158.88
2025-10-15BUY189170.720173.020 172.790GBX 32,657 158.82
2025-10-14BUY27170.130172.410 172.182GBX 4,649 158.76
2025-10-06BUY135174.950179.640 179.171GBX 24,188 158.61
2025-10-03BUY54177.330181.450 181.038GBX 9,776 158.51
2025-10-02BUY27175.360178.190 177.907GBX 4,803 158.42
2025-10-01BUY158170.480170.660 170.642GBX 26,961 158.36
2025-09-18BUY27156.990157.630 157.566GBX 4,254 158.61
2025-09-11BUY27159.740159.780 159.776GBX 4,314 158.68
2025-09-10BUY27153.270157.970 157.500GBX 4,253 158.71
2025-08-20BUY54159.580159.620 159.616GBX 8,619 158.72
2025-08-19BUY27158.480160.000 159.848GBX 4,316 158.72
2025-07-17SELL-27156.700156.950 156.925GBX -4,237 158.78 Profit of 50 on sale
2025-07-15SELL-108154.420159.490 158.983GBX -17,170 158.83 Loss of -16 on sale
2025-07-14SELL-270158.040160.410 160.173GBX -43,247 158.84 Loss of -361 on sale
2025-07-09SELL-27158.970163.590 163.128GBX -4,404 158.80 Loss of -117 on sale
2025-07-07SELL-54153.900156.720 156.438GBX -8,448 158.84 Profit of 129 on sale
2025-07-02BUY27157.490158.380 158.291GBX 4,274 158.87
2025-06-24SELL-459148.400149.680 149.552GBX -68,644 159.15 Profit of 4,404 on sale
2025-06-23BUY27147.380148.320 148.226GBX 4,002 159.23
2025-06-20SELL-1,403147.450147.740 147.711GBX -207,239 159.30 Profit of 16,266 on sale
2025-06-18SELL-28145.290147.100 146.919GBX -4,114 159.50 Profit of 352 on sale
2025-06-17BUY336145.050150.540 149.991GBX 50,397 159.59
2025-06-13SELL-56149.450152.640 152.321GBX -8,530 159.72 Profit of 415 on sale
2025-06-11SELL-28151.110154.430 154.098GBX -4,315 159.84 Profit of 161 on sale
2025-06-10SELL-56151.000152.430 152.287GBX -8,528 159.90 Profit of 426 on sale
2025-06-09SELL-84147.460149.030 148.873GBX -12,505 159.99 Profit of 934 on sale
2025-05-21SELL-28134.980141.710 141.037GBX -3,949 162.24 Profit of 594 on sale
2025-05-20SELL-56143.530143.820 143.791GBX -8,052 162.38 Profit of 1,041 on sale
2025-05-15SELL-84138.890139.380 139.331GBX -11,704 162.92 Profit of 1,981 on sale
2025-05-14SELL-84138.950146.430 145.682GBX -12,237 163.12 Profit of 1,465 on sale
2025-05-13BUY28144.020145.640 145.478GBX 4,073 163.27
2025-05-09SELL-28138.790143.460 142.993GBX -4,004 163.65 Profit of 578 on sale
2025-05-08BUY56141.360143.860 143.610GBX 8,042 163.84
2025-05-01BUY56116.890120.140 119.815GBX 6,710 165.72
2025-04-24SELL-28115.760115.940 115.922GBX -3,246 168.00 Profit of 1,458 on sale
2025-04-23BUY84109.000116.060 115.354GBX 9,690 168.56
2025-04-15SELL-28105.920107.580 107.414GBX -3,008 172.31 Profit of 1,817 on sale
2025-04-11SELL-5699.750101.360 101.199GBX -5,667 173.71 Profit of 4,061 on sale
2025-04-08SELL-28123.610137.960 136.525GBX -3,823 175.36 Profit of 1,087 on sale
2025-04-07SELL-28134.070139.160 138.651GBX -3,882 175.79 Profit of 1,040 on sale
2025-04-04SELL-56136.900140.150 139.825GBX -7,830 176.21 Profit of 2,037 on sale
2025-04-02BUY28149.280150.160 150.072GBX 4,202 176.50
2025-04-01BUY252145.990151.370 150.832GBX 38,010 176.83
2025-03-31SELL-168150.520153.820 153.490GBX -25,786 177.12 Profit of 3,970 on sale
2025-03-28BUY28155.550158.710 158.394GBX 4,435 177.36
2025-03-26SELL-19158.250162.320 161.913GBX -3,076 177.80 Profit of 302 on sale
2025-03-21BUY196167.280167.940 167.874GBX 32,903 178.24
2025-03-20BUY112165.350171.710 171.074GBX 19,160 178.39
2025-03-17SELL-28175.010175.600 175.541GBX -4,915 178.51 Profit of 83 on sale
2025-03-12BUY1,035170.590171.190 171.130GBX 177,120 178.85
2025-03-07BUY27175.920177.240 177.108GBX 4,782 179.11
2025-02-28SELL-81165.310165.820 165.769GBX -13,427 179.89 Profit of 1,144 on sale
2025-02-25BUY270167.100172.430 171.897GBX 46,412 180.48
2025-02-20BUY189162.250168.020 167.443GBX 31,647 181.18
2025-02-19BUY81165.000166.440 166.296GBX 13,470 181.43
2025-02-18BUY54154.390155.690 155.560GBX 8,400 181.86
2025-02-13BUY135153.170155.290 155.078GBX 20,936 183.33
2025-02-04BUY108163.120169.670 169.015GBX 18,254 186.27
2025-01-31BUY27164.760167.090 166.857GBX 4,505 187.17
2025-01-29BUY27161.640163.000 162.864GBX 4,397 188.13
2025-01-27BUY54165.840168.550 168.279GBX 9,087 189.13
2025-01-24BUY27164.970168.150 167.832GBX 4,531 189.66
2025-01-22BUY108168.220170.830 170.569GBX 18,421 190.66
2024-12-10SELL-27197.050202.720 202.153GBX -5,458 194.71 Loss of -201 on sale
2024-12-09SELL-702201.750202.570 202.488GBX -142,147 194.49 Loss of -5,617 on sale
2024-12-03SELL-324199.300201.120 200.938GBX -65,104 194.34 Loss of -2,137 on sale
2024-12-02SELL-135201.250203.010 202.834GBX -27,383 194.09 Loss of -1,181 on sale
2024-11-29SELL-27199.060201.290 201.067GBX -5,429 193.89 Loss of -194 on sale
2024-11-22SELL-270195.770198.180 197.939GBX -53,444 192.73 Loss of -1,407 on sale
2024-11-21SELL-135194.190194.880 194.811GBX -26,299 192.65 Loss of -291 on sale
2024-11-20BUY216187.900188.320 188.278GBX 40,668 192.90
2024-11-18SELL-324187.500187.930 187.887GBX -60,875 193.62 Profit of 1,858 on sale
2024-11-11BUY243220.690222.100 221.959GBX 53,936 190.33
2024-11-08SELL-864215.390216.150 216.074GBX -186,688 188.54 Loss of -23,789 on sale
2024-11-07SELL-54210.290217.600 216.869GBX -11,711 186.87 Loss of -1,620 on sale
2024-11-01SELL-54180.960184.040 183.732GBX -9,922 184.77 Profit of 56 on sale
2024-10-31SELL-108178.580181.230 180.965GBX -19,544 185.55 Profit of 495 on sale
2024-10-30BUY27181.390186.370 185.872GBX 5,019 186.14
2024-10-29BUY162184.000186.460 186.214GBX 30,167 186.50
2024-10-28SELL-81186.520188.000 187.852GBX -15,216 186.49 Loss of -110 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of CRL

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-1998,1391131,07574.9%
2025-09-1862,9972121,43651.9%
2025-09-1792,1290727,00512.7%
2025-09-16115,39612317,67336.3%
2025-09-1566,3561151,09343.9%
2025-09-1277,5570176,81743.9%
2025-09-1187,9991204,23743.1%
2025-09-10122,6560398,56430.8%
2025-09-09125,4020471,64226.6%
2025-09-08178,3420414,72943.0%
2025-09-0576,2640192,66839.6%
2025-09-0494,7920179,53352.8%
2025-09-03139,6460216,26564.6%
2025-09-02112,81930183,91061.3%
2025-08-29105,9651,040180,20658.8%
2025-08-28183,9714248,97873.9%
2025-08-2771,8910134,03453.6%
2025-08-26109,85319166,15266.1%
2025-08-25147,16623300,78148.9%
2025-08-22251,1260414,08560.6%
2025-08-21102,1520149,37668.4%
2025-08-20152,7210215,94670.7%
2025-08-19118,8310172,88768.7%
2025-08-1893,0280164,64156.5%
2025-08-1596,5001180,16553.6%
2025-08-14147,9520251,45658.8%
2025-08-13820,20601,075,15376.3%
2025-08-12299,3220438,69968.2%
2025-08-11192,9170365,05852.8%
2025-08-0892,08966222,12841.5%
2025-08-07326,647522550,23059.4%
2025-08-06532,4347,827888,87359.9%
2025-08-05283,1486539,93852.4%
2025-08-04124,11154248,83449.9%
2025-08-01162,441300281,62257.7%
2025-07-31125,6480228,70654.9%
2025-07-30115,4870188,12161.4%
2025-07-29181,1590275,84365.7%
2025-07-28198,89649321,94161.8%
2025-07-25162,642111293,83155.4%
2025-07-24385,658456820,47247.0%
2025-07-23150,6500346,02043.5%
2025-07-22205,73626821,85325.0%
2025-07-21132,794101445,92029.8%
2025-07-1893,150207186,54249.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.